Synthesis and Biological Activities of Some 1,2,4-Triazole Derivatives: A Review

Authors

  • Dina Saleem M. Ameen Pharmaceutical Chemistry Department, College of Pharmacy, Mustansiriyah University, Baghdad-Iraq
  • Mohammed Dheyaa Hamdi Pharmaceutical Chemistry Department, College of Pharmacy, Mustansiriyah University, Baghdad-Iraq
  • Ayad Kareem Khan Pharmaceutical Chemistry Department, College of Pharmacy, Mustansiriyah University, Baghdad-Iraq

DOI:

https://doi.org/10.32947/ajps.v22i3.890

Keywords:

Heterocyclic, Triazole, Biological Activities

Abstract

This review is about 1,2,4-triazoles include their synthesis; their physio-chemical properties, SAR, reactions, derivatives. Finally, their biological activities with a demonstrated showing

 

different requirements to achieve different activity

References

- Strzelecka, M. and P. Świątek, 1, 2, 4-Triazoles as Important Antibacterial Agents. Pharmaceuticals, 2021. 14(3): p. 224.

- Maddila, S., R. Pagadala, and S. B Jonnalagadda, 1, 2, 4-Triazoles: A review of synthetic approaches and the biological activity. Letters in Organic Chemistry, 2013. 10(10): p. 693-714.

- Bihdan, O.A., et al., 1, 2, 4-Triazole derivatives with halogen substituted fragments, their synthesis, modification and biological properties. Research Journal of Pharmaceutical Biological and Chemical Sciences, 2018. 9(1): p. 22-29.

- Shahzadi, I., et al., Synthesis, Hemolytic Studies, and In Silico Modeling of Novel Acefylline–1, 2, 4-Triazole Hybrids as Potential Anti-cancer Agents against MCF-7 and A549. ACS omega, 2021. 6(18): p. 11943-11953.

- Jiang, B., et al., Corrosion inhibition performance of triazole derivatives on Copper-Nickel alloy in 3.5 wt.% NaCl solution. Journal of Materials Engineering and Performance, 2015. 24(12): p. 4797-4808.

- Miller, S.A., J.P. Ferreira, and J.T. LeJeune, Antimicrobial Use and Resistance in Plant Agriculture: A One Health Perspective. Agriculture, 2022. 12(2): p. 289.

- Pereira, D., et al., Recent Advances in Bioactive Flavonoid Hybrids Linked by 1, 2, 3-Triazole Ring Obtained by Click Chemistry. Molecules, 2021. 27(1): p. 230.

- Aflak, N., et al., Sustainable construction of heterocyclic 1, 2, 3-triazoles by strict click [3+ 2] cycloaddition reactions between azides and alkynes on copper/carbon in water. Frontiers in chemistry, 2019. 7: p. 81.

- Gupta, R.R., M. Kumar, and V. Gupta, Heterocyclic Chemistry: Volume II: Five-Membered Heterocycles. 2013: Springer Science & Business Media.

- Ranasinghe, N., et al., Flow and Microwave Induced Pellizzari Reactions: Synthesis of Heterocyclic Analogues of the Benzoxazepine Antipsychotic Agents Loxapine and JL-13. Advances in Chemistry, 2017. 2017.

- Atkinson, M. and J. Polya, 657. Triazoles. Part I. Unsymmetrical Einhorn–Brunner and related Pellizzari reactions. Journal of the Chemical Society (Resumed), 1952: p. 3418-3422.

- Kaur, P. and A. Chawla, 1, 2, 4-Triazole: a review of pharmacological activities. Int. Res. J. Pharm, 2017. 8(7): p. 10-29.

- Wang, L.-Y., et al., One-flask synthesis of 1, 3, 5-trisubstituted 1, 2, 4-triazoles from nitriles and hydrazonoyl chlorides via 1, 3-dipolar cycloaddition. RSC Advances, 2014. 4(27): p. 14215-14220.

- Saavedra, J.Z., et al., Reaction of InCl3 with various reducing agents: InCl3–NaBH4-mediated reduction of aromatic and aliphatic nitriles to primary amines. The Journal of Organic Chemistry, 2012. 77(1): p. 221-228.

- Miura, T., et al., Regioselective 1, 3-Dipolar Cycloaddition of Nitriles with Nitrile Imines Generated from Tetrazoles. Chemistry Letters, 2021. 50(1): p. 131-135.

- Yang, D., et al., Copper‐Catalyzed Synthesis of 1, 2, 4‐Benzothiadiazine 1, 1‐Dioxide Derivatives by Coupling of 2‐Halobenzenesulfonamides with Amidines. Advanced Synthesis & Catalysis, 2009. 351(11‐12): p. 1999-2004.

- Xu, H., et al., Copper-catalyzed one-pot synthesis of 1, 2, 4-triazoles from nitriles and hydroxylamine. The Journal of Organic Chemistry, 2015. 80(3): p. 1789-1794.

- Hassan, S. and T.J. Mueller, Multicomponent Syntheses based upon Copper‐Catalyzed Alkyne‐Azide Cycloaddition. Advanced Synthesis & Catalysis, 2015. 357(4): p. 617-666.

- Lee, J., et al., Synthesis of 1, 3, 5-trisubstituted-1, 2, 4-triazoles by microwave-assisted N-acylation of amide derivatives and the consecutive reaction with hydrazine hydrochlorides. Tetrahedron, 2012. 68(8): p. 2045-2051.

- Van Otterlo, W.A. and I.R. Green, A review on recent syntheses of Amaryllidaceae alkaloids and isocarbostyrils (time period mid-2016 to 2017). Natural Product Communications, 2018. 13(3): p. 1934578X1801300305.

- de la Hoz, A., A. Díaz-Ortiz, and P. Prieto, Microwave-assisted green organic synthesis. 2016.

- Guihéneuf, K.W.C., et al., Microwaves in Heterocyclic Chemistry. Synthesis, 2012. 16: p. 1.

- Suramwar, N.V., S.R. Thakare, and N.T. Khaty, Room Temperature N-Arylation of 1, 2, 4-Triazoles under Ligand-Free Condition. Organic Chemistry International, 2012. 2012.

- Domini, C.E., et al., Merging metallic catalysts and sonication: A periodic table overview. Catalysts, 2017. 7(4): p. 121.

- Cristau, H.J., et al., Highly efficient and mild copper‐catalyzed N‐and C‐arylations with aryl bromides and iodides. Chemistry–A European Journal, 2004. 10(22): p. 5607-5622.

- MALANI, A.H., A.H. Makwana, and H.R. Makwana, A brief review article: Various synthesis and therapeutic importance of 1, 2, 4-triazole and its derivatives. Moroccan Journal of Chemistry, 2017. 5(1): p. 5-1 (2017) 41-58.

- Zheng, Y.-Y., et al., Study of benzofuroquinolinium derivatives as a new class of potent antibacterial agent and the mode of inhibition targeting FtsZ. Frontiers in Microbiology, 2018: p. 1937.

- Smith, I., Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical Microbiology Reviews, 2003. 16(3): p. 463-496.

- Seung, K.J., S. Keshavjee, and M.L. Rich, Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harbor Perspectives in Medicine, 2015. 5(9): p. a017863.

- Küçükgüzel, I., et al., Synthesis of some 3-(arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1, 2, 4-triazole derivatives and their anticonvulsant activity. Il Farmaco, 2004. 59(11): p. 893-901.

- Nguyen, T.-T., et al., In vitro antimycobacterial studies of flavonols from Bauhinia vahlii Wight and Arn. Biotech, 2021. 11(3): p. 1-5.

- Tan, Z., et al., Triazole-containing hybrids with anti-Mycobacterium tuberculosis potential–Part I: 1, 2, 3-Triazole. Future Medicinal Chemistry, 2021. 13(07): p. 643-662.

- Hargrove, T.Y., et al., Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. Journal of Biological Chemistry, 2017. 292(16): p. 6728-6743.

- Zuccolo, M., et al., Dual-active antifungal agents containing strobilurin and SDHI-based pharmacophores. Scientific Reports, 2019. 9(1): p. 1-12.

- Gavara, L., et al., 4-Amino-1, 2, 4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors. European Journal of Medicinal Chemistry, 2020. 208: p. 112720.

- Strasfeld, L. and S. Chou, Antiviral drug resistance: mechanisms and clinical implications. Infectious Disease Clinics, 2010. 24(3): p. 809-833.

- Coelmont, L., et al., Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2′-C-methylcytidine, the active component of valopicitabine. Antimicrobial agents and chemotherapy, 2006. 50(10): p. 3444-3446.

- Martins, P., et al., Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine’s tool box. Molecules, 2015. 20(9): p. 16852-16891.

- Rashdan, H.R. and I.A. Shehadi, Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment. Heteroatom Chemistry, 2022. 2022.

- Prachayasittikul, V., et al., Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives. Drug Design, Development and Therapy, 2014. 8: p. 1089.

- Kharb, R., P.C. Sharma, and M.S. Yar, Pharmacological significance of triazole scaffold. Journal of enzyme inhibition and medicinal chemistry, 2011. 26(1): p. 1-21.

- Guo, H.-Y., et al., Application of triazoles in the structural modification of natural products. Journal of Enzyme Inhibition and Medicinal Chemistry, 2021. 36(1): p. 1115-1144.

- Parker, J.E., et al., Resistance to antifungals that target CYP51. Journal of Chemical Biology, 2014. 7(4): p. 143-161.

- Sheehan, D.J., C.A. Hitchcock, and C.M. Sibley, Current and emerging azole antifungal agents. Clinical microbiology reviews, 1999. 12(1): p. 40-79.

- Pianalto, K.M. and J.A. Alspaugh, New horizons in antifungal therapy. Journal of Fungi, 2016. 2(4): p. 26.

- Maza, S., et al., Synthesis, structural investigation and NLO properties of three 1, 2, 4-triazole Schiff bases. Journal of Molecular Structure, 2020. 1219: p. 128492.

- Mast, N., et al., Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1. Molecular Pharmacology, 2013. 84(1): p. 86-94.

- Warrilow, A.G., et al., Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Antimicrobial agents and chemotherapy, 2013. 57(3): p. 1352-1360.

- Monk, B.C., et al., Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2020. 1868(3): p. 140206.

- Sagatova, A.A., et al., Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14α-demethylase. Antimicrobial agents and chemotherapy, 2015. 59(8): p. 4982-4989.

- Sagatova, A.A., et al., Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14α-demethylase. Scientific reports, 2016. 6(1): p. 1-11.

- Gupta, V.K., R.L. Mach, and S. Sreenivasaprasad, Fungal Biomolecules: sources, applications and recent developments. John Wiley & Sons, 2015.

- Senerovic, L., et al., Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agents. Advances in Microbiology, Infectious Diseases and Public Health, 2019: p. 37-69.

- Nguyen, L.A., H. He, and C. Pham-Huy, Chiral drugs: an overview. International journal of biomedical science: IJBS, 2006. 2(2): p. 85.

- Kumari, S., et al., Amide bond bioisosteres: Strategies, synthesis, and successes. Journal of Medicinal Chemistry, 2020. 63(21): p. 12290-12358.

- Kazeminejad, Z., et al., Novel 1, 2, 4-Triazoles as Antifungal Agents. BioMed Research International, 2022. 2022.

- Ley, S.V., Quaternary stereocenters: challenges and solutions for organic synthesis. John Wiley & Sons, 2006

- Heeres, J., L. Meerpoel, and P. Lewi, Conazoles. Molecules, 2010. 15(6): p. 4129-4188.

- Chen, A.Y., et al., Targeting metalloenzymes for therapeutic intervention. Chemical reviews, 2018. 119(2): p. 1323-1455.

- Xie, L., et al., Harzianic acid from Trichoderma afroharzianum is a natural product inhibitor of acetohydroxyacid synthase. Journal of the American Chemical Society, 2021. 143(25): p. 9575-9584.

- Deming, T.J., Synthesis of side-chain modified polypeptides. Chemical reviews, 2016. 116(3): p. 786-808.

- Liu, X., et al., Antifungal compounds against Candida infections from traditional Chinese medicine. BioMed Research International, 2017. 2017.

- Zhou, H.-X. and X. Pang, Electrostatic interactions in protein structure, folding, binding, and condensation. Chemical reviews, 2018. 118(4): p. 1691-1741.

- Lepak, A.J. and D.R. Andes, Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harbor Perspectives in Medicine, 2015. 5(5): p. a019653.

- Singh, S., Chemistry, design, and structure− activity relationship of cocaine antagonists. Chemical reviews, 2000. 100(3): p. 925-1024.

- Lommerse, J.P., S.L. Price, and R. Taylor, Hydrogen bonding of carbonyl, ether, and ester oxygen atoms with alkanol hydroxyl groups. Journal of computational chemistry, 1997. 18(6): p. 757-774.

- Dalvit, C., C. Invernizzi, and A. Vulpetti, Fluorine as a hydrogen‐bond acceptor: Experimental evidence and computational calculations. Chemistry–A European Journal, 2014. 20(35): p. 11058-11068.

- Matin, M.M., et al., Triazoles and their derivatives: Chemistry, synthesis, and therapeutic applications. Frontiers in molecular biosciences, 2022: p. 303.

- Viegas, D.J., et al., Antiviral activity of 1, 4-disubstituted-1, 2, 3-triazoles against HSV-1 in vitro. Antiviral Therapy, 2020. 25(8): p. 399-410.

- Kokoris, M.S. and M.E. Black, Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein science, 2002. 11(9): p. 2267-2272.

- Lauria, A., et al., 1, 2, 3‐Triazole in heterocyclic compounds, endowed with biological activity, through 1, 3‐dipolar cycloadditions. European Journal of Organic Chemistry, 2014. 2014(16): p. 3289-3306.

- Vértessy, B.G. and J. Tóth, Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases. Accounts of chemical research, 2009. 42(1): p. 97-106.

- Montana, M., et al., Quinoxaline derivatives as antiviral agents: a systematic review. Molecules, 2020. 25(12): p. 2784.

- Sebastian, L., et al., Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin. International journal of antimicrobial agents, 2009. 33(2): p. 168-173.

- Musharrafieh, R., et al., Development of broad-spectrum enterovirus antivirals based on quinoline scaffold. Bioorganic chemistry, 2020. 101: p. 103981.

- Ji, X. and Z. Li, Medicinal chemistry strategies toward host targeting antiviral agents. Medicinal Research Reviews, 2020. 40(5): p. 1519-1557.

- Seck, I. and F. Nguemo, Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus. Results in chemistry, 2021. 3: p. 100132.

- Xiao, Y., et al., Synthesis of 10, 10′-bis (trifluoromethyl) marinopyrrole A derivatives and evaluation of their antiviral activities in vitro. European Journal of Medicinal Chemistry, 2022. 238: p. 114436.

- Hernández-López, H., et al., Synthesis of 1, 4-biphenyl-triazole derivatives as possible 17β-HSD1 inhibitors: An in Silico Study. ACS omega, 2020. 5(23): p. 14061-14068.

- Zhang, Y., et al., Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine. Human Vaccines & Immunotherapeutics, 2015. 11(7): p. 1803-1813.

- Alsayed, S.S., et al., Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis. Bioorganic chemistry, 2021. 106: p. 104486.

Downloads

Published

2022-10-24